Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 26 |
| List of Tables | 24 | 3 |
| List of Figures | 27 | 1 |
| Introduction | 28 | 1 |
| Global Markets Direct Report Coverage | 28 | 1 |
| Tuberculosis Overview | 29 | 1 |
| Therapeutics Development | 30 | 2 |
| Pipeline Products for Tuberculosis Overview | 30 | 1 |
| Pipeline Products for Tuberculosis Comparative Analysis | 31 | 1 |
| Tuberculosis Therapeutics under Development by Companies | 32 | 5 |
| Tuberculosis Therapeutics under Investigation by Universities/Institutes | 37 | 3 |
| Tuberculosis Pipeline Products Glance | 40 | 4 |
| Late Stage Products | 40 | 1 |
| Clinical Stage Products | 41 | 1 |
| Early Stage Products | 42 | 1 |
| Unknown Stage Products | 43 | 1 |
| Tuberculosis Products under Development by Companies | 44 | 7 |
| Tuberculosis Products under Investigation by Universities/Institutes | 51 | 5 |
| Tuberculosis Companies Involved in Therapeutics Development | 56 | 64 |
| Abera Bioscience AB | 56 | 1 |
| Akthelia Pharmaceuticals Limited | 57 | 1 |
| Alvogen Korea Co., Ltd. | 58 | 1 |
| Anacor Pharmaceuticals, Inc. | 59 | 1 |
| Archivel Farma S.L. | 60 | 1 |
| AstraZeneca Plc | 61 | 1 |
| Beech Tree Labs, Inc. | 62 | 1 |
| BioDiem Ltd | 63 | 1 |
| BioLingus AG | 64 | 1 |
| Biomar Microbial Technologies | 65 | 1 |
| Bioversys AG | 66 | 1 |
| Celgene Corporation | 67 | 1 |
| Cellceutix Corporation | 68 | 1 |
| Chongqing Zhifei Biological Products Co., Ltd. | 69 | 1 |
| Crestone, Inc. | 70 | 1 |
| Dafra Pharma International Ltd. | 71 | 1 |
| Daiichi Sankyo Company, Limited | 72 | 1 |
| Demuris Limited | 73 | 1 |
| Eisai Co., Ltd. | 74 | 1 |
| Eli Lilly and Company | 75 | 1 |
| Ensol Biosciences Inc. | 76 | 1 |
| EpiVax, Inc. | 77 | 1 |
| FIT Biotech Oy | 78 | 1 |
| GangaGen Inc. | 79 | 1 |
| GlaxoSmithKline Plc | 80 | 1 |
| Globeimmune, Inc. | 81 | 1 |
| Hager Biosciences, LLC | 82 | 1 |
| Hsiri Therapeutics LLC | 83 | 1 |
| Imaxio SA | 84 | 1 |
| Immunitor, Inc. | 85 | 1 |
| ImmunoBiology Limited | 86 | 1 |
| Inovio Pharmaceuticals, Inc. | 87 | 1 |
| Johnson &Johnson | 88 | 1 |
| Lakewood-Amedex Inc | 89 | 1 |
| Lipotek Pty Ltd. | 90 | 1 |
| Matinas BioPharma Holdings, Inc. | 91 | 1 |
| Microbion Corporation | 92 | 1 |
| Microbiotix, Inc. | 93 | 1 |
| NEARMEDIC PLUS, Ltd | 94 | 1 |
| Novartis AG | 95 | 1 |
| NovoBiotic Pharmaceuticals, LLC | 96 | 1 |
| Otsuka Holdings Co., Ltd. | 97 | 1 |
| QureTech Bio AB | 98 | 1 |
| Recce Pty Ltd | 99 | 1 |
| Rodos BioTarget GmbH | 100 | 1 |
| Sanofi | 101 | 1 |
| Sanofi Pasteur SA | 102 | 1 |
| Sarepta Therapeutics, Inc. | 103 | 1 |
| Sequella, Inc. | 104 | 1 |
| Shionogi &Co., Ltd. | 105 | 1 |
| Sphaera Pharma Pvt. Ltd. | 106 | 1 |
| Spring Bank Pharmaceuticals, Inc. | 107 | 1 |
| Takeda Pharmaceutical Company Limited | 108 | 1 |
| TetraLogic Pharmaceuticals | 109 | 1 |
| TGV-Laboratories | 110 | 1 |
| Theravectys SA | 111 | 1 |
| Tomegavax, Inc. | 112 | 1 |
| Transgene SA | 113 | 1 |
| TVAX Biomedical, Inc. | 114 | 1 |
| Univalue Valorizacion, S.L. | 115 | 1 |
| Vaccibody AS | 116 | 1 |
| Vakzine Projekt Management GmbH | 117 | 1 |
| Vaxil Bio Therapeutics Ltd. | 118 | 1 |
| Vichem Chemie Research Ltd. | 119 | 1 |
| Tuberculosis Therapeutics Assessment | 120 | 12 |
| Assessment by Monotherapy Products | 120 | 1 |
| Assessment by Combination Products | 121 | 1 |
| Assessment by Target | 122 | 3 |
| Assessment by Mechanism of Action | 125 | 3 |
| Assessment by Route of Administration | 128 | 2 |
| Assessment by Molecule Type | 130 | 2 |
| Drug Profiles | 132 | 234 |
| (HIV + tuberculosis) vaccine Drug Profile | 132 | 1 |
| (leprosy + pulmonary tuberculosis) vaccine Drug Profile | 133 | 2 |
| Ab-02 Drug Profile | 135 | 1 |
| AKT-10081 Drug Profile | 136 | 1 |
| aldesleukin Drug Profile | 137 | 1 |
| AM-009 Drug Profile | 138 | 1 |
| AST-1753 Drug Profile | 139 | 1 |
| Bacterial PPMO Drug Profile | 140 | 1 |
| BBH-7 Drug Profile | 141 | 1 |
| BDM-I Drug Profile | 142 | 3 |
| bedaquiline fumarate Drug Profile | 145 | 4 |
| birinapant Drug Profile | 149 | 7 |
| bladder cancer + pertussis + tuberculosis vaccine Drug Profile | 156 | 1 |
| BTL-slo Drug Profile | 157 | 1 |
| BTP-15 Drug Profile | 158 | 1 |
| BV-6481 Drug Profile | 159 | 1 |
| capreomycin sulfate Drug Profile | 160 | 1 |
| CC-11050 Drug Profile | 161 | 1 |
| clofazimine Drug Profile | 162 | 1 |
| CPZEN-45 Drug Profile | 163 | 1 |
| CWGNC-41 Drug Profile | 164 | 1 |
| DAR-901 Drug Profile | 165 | 1 |
| DC-159a Drug Profile | 166 | 1 |
| delamanid Drug Profile | 167 | 2 |
| DF-152 Drug Profile | 169 | 1 |
| EDE-1203 Drug Profile | 170 | 1 |
| FS-1 Drug Profile | 171 | 1 |
| GI-19000 Drug Profile | 172 | 1 |
| GSK-070 Drug Profile | 173 | 1 |
| GSK-147 Drug Profile | 174 | 1 |
| GSK-3011724A Drug Profile | 175 | 1 |
| GSK-692342 Drug Profile | 176 | 2 |
| H-64 Drug Profile | 178 | 1 |
| Hesed-1000 Drug Profile | 179 | 1 |
| HG-85A Drug Profile | 180 | 1 |
| HG-85A/B Drug Profile | 181 | 1 |
| HG856-A Drug Profile | 182 | 1 |
| HG856-BCG Drug Profile | 183 | 1 |
| HG856-SeV Drug Profile | 184 | 1 |
| HT-04 Drug Profile | 185 | 1 |
| ID-93 Drug Profile | 186 | 2 |
| IMX-313-TB Drug Profile | 188 | 1 |
| infectious disease vaccine Drug Profile | 189 | 1 |
| interleukin 2 Drug Profile | 190 | 1 |
| KKL-35 Drug Profile | 191 | 1 |
| lassomycin Drug Profile | 192 | 1 |
| LCB-010371 Drug Profile | 193 | 2 |
| Lipovax-Flic-TB Drug Profile | 195 | 1 |
| MDN-0080 Drug Profile | 196 | 1 |
| MDN-0096 Drug Profile | 197 | 1 |
| MT-3001 Drug Profile | 198 | 1 |
| MTbuVax Drug Profile | 199 | 1 |
| MTBVAC-01 Drug Profile | 200 | 1 |
| MVA-85A Drug Profile | 201 | 3 |
| NC-00094221 Drug Profile | 204 | 1 |
| ND-09759 Drug Profile | 205 | 1 |
| NITD-304 Drug Profile | 206 | 1 |
| NITD-349 Drug Profile | 207 | 1 |
| NITD-916 Drug Profile | 208 | 1 |
| Novo-23 Drug Profile | 209 | 1 |
| Nu-3 Drug Profile | 210 | 2 |
| P-128 Drug Profile | 212 | 1 |
| PBTZ-169 Drug Profile | 213 | 1 |
| Peptides for Tuberculosis Drug Profile | 214 | 1 |
| PMX-10072 Drug Profile | 215 | 1 |
| pretomanid Drug Profile | 216 | 3 |
| pulmonary tuberculosis vaccine Drug Profile | 219 | 1 |
| Q-203 Drug Profile | 220 | 1 |
| QR-109 Drug Profile | 221 | 1 |
| RBT-10 Drug Profile | 222 | 1 |
| RSQ-15 Drug Profile | 223 | 1 |
| RUTI Drug Profile | 224 | 1 |
| S-006830 Drug Profile | 225 | 1 |
| SB-9922 Drug Profile | 226 | 1 |
| SBP-17GA20 Drug Profile | 227 | 1 |
| SEQ-9 Drug Profile | 228 | 1 |
| Small Molecule 2 for Tuberculosis Drug Profile | 229 | 1 |
| Small Molecule 3 for Tuberculosis Drug Profile | 230 | 1 |
| Small Molecule 4 for Tuberculosis Drug Profile | 231 | 1 |
| Small Molecule for Malaria and Bacterial Infections Drug Profile | 232 | 1 |
| Small Molecule for Pneumonia, COPD, Cystic Fibrosis and Pulmonary Tuberculosis Drug Profile | 233 | 1 |
| Small Molecule for Staphylococcus Aureus Infections and Tuberculosis Drug Profile | 234 | 1 |
| Small Molecule for Tuberculosis Drug Profile | 235 | 1 |
| Small Molecule for Tuberculosis Drug Profile | 236 | 1 |
| Small Molecule for Tuberculosis Drug Profile | 237 | 1 |
| Small Molecule for Tuberculosis Drug Profile | 238 | 1 |
| Small Molecule to Inhibit Beta Sliding Clamp for Tuberculosis Drug Profile | 239 | 1 |
| Small Molecule to Inhibit CysK1 for Tuberculosis Drug Profile | 240 | 1 |
| Small Molecule to Inhibit DNA Gyrase for Tuberculosis Drug Profile | 241 | 1 |
| Small Molecule to Inhibit DNA-Directed RNA Polymerase Subunit Beta and HIV Integrase for HIV and Tuberculosis Drug Profile | 242 | 1 |
| Small Molecule to Inhibit F0F1-ATP Synthase for Tuberculosis Drug Profile | 243 | 1 |
| Small Molecule to Inhibit MmpL3 for Tuberculosis Drug Profile | 244 | 1 |
| Small Molecule to Inhibit Pks13 for Tuberculosis Drug Profile | 245 | 1 |
| Small Molecule to Target Bacterial Cell Wall for Gonorrhoea and Tuberculosis Drug Profile | 246 | 1 |
| Small Molecule to Target InhA for Tuberculosis Drug Profile | 247 | 1 |
| Small Molecule to Target Mycobacterial Biofilms for Tuberculosis Drug Profile | 248 | 1 |
| Small Molecules 2 for Tuberculosis Drug Profile | 249 | 1 |
| Small Molecules for Infectious Disease Drug Profile | 250 | 1 |
| Small Molecules for Infectious Diseases Drug Profile | 251 | 1 |
| Small Molecules for Infectious Diseases Drug Profile | 252 | 1 |
| Small Molecules for Infectious Diseases Drug Profile | 253 | 1 |
| Small Molecules for Multiresistant Tuberculosis Drug Profile | 254 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 255 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 256 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 257 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 258 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 259 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 260 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 261 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 262 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 263 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 264 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 265 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 266 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 267 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 268 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 269 | 1 |
| Small Molecules for Tuberculosis Drug Profile | 270 | 1 |
| Small Molecules for Tuberculosis and Mycobacterial Infections Drug Profile | 271 | 1 |
| Small Molecules to Activate Perforin-2 Synthesis for Bacterial Infections Drug Profile | 272 | 1 |
| Small Molecules to Antagonize Folate Receptor for Tuberculosis Drug Profile | 273 | 1 |
| Small Molecules to Inhibit 16S rRNA for Tuberculosis Drug Profile | 274 | 1 |
| Small Molecules to Inhibit 50S RNA for Bacterial Infections and Tuberculosis Drug Profile | 275 | 1 |
| Small Molecules to Inhibit Alanine Racemase for Tuberculosis and MRSA Infections Drug Profile | 276 | 1 |
| Small Molecules to Inhibit APS Reductase for Tuberculosis Drug Profile | 277 | 1 |
| Small Molecules to Inhibit ATP Synthesis for Tuberculosis Drug Profile | 278 | 1 |
| Small Molecules to Inhibit Cytochrome bc1 Complex for Tuberculosis Drug Profile | 279 | 1 |
| Small Molecules to Inhibit DHFR for Tuberculosis Drug Profile | 280 | 1 |
| Small Molecules to Inhibit DNA gyrase and AddAB /RecBCD helicase for Tuberculosis Drug Profile | 281 | 1 |
| Small Molecules to Inhibit DNA Gyrase for Tuberculosis Drug Profile | 282 | 1 |
| Small Molecules to Inhibit DNA GyrB for Tuberculosis Drug Profile | 283 | 1 |
| Small Molecules to Inhibit DprE1 for Tuberculosis Drug Profile | 284 | 1 |
| Small Molecules to Inhibit DprE1 for Tuberculosis Drug Profile | 285 | 1 |
| Small Molecules to Inhibit DXR for Malaria and Tuberculosis Drug Profile | 286 | 1 |
| Small Molecules to Inhibit FtsZ for Tuberculosis Drug Profile | 287 | 1 |
| Small Molecules to Inhibit Hypoxanthine Phosphoribosyltransferase for Malaria and Tuberculosis Drug Profile | 288 | 1 |
| Small Molecules to Inhibit InhA for Tuberculosis Drug Profile | 289 | 1 |
| Small Molecules to Inhibit L,D-Transpeptidase for Tuberculosis Drug Profile | 290 | 1 |
| Small Molecules to Inhibit Leucyl-tRNA Synthetase for Tuberculosis Drug Profile | 291 | 1 |
| Small Molecules to Inhibit MmpL3 for Tuberculosis Drug Profile | 292 | 1 |
| Small Molecules to Inhibit PBPs for Tuberculosis Drug Profile | 293 | 1 |
| Small Molecules to Inhibit Protein Kinase B for Tuberculosis Drug Profile | 294 | 1 |
| Small Molecules to Inhibit RelMtb for Tuberculosis Drug Profile | 295 | 1 |
| Small Molecules to Inhibit RNA Polymerase for Bacterial Infections and Tuberculosis Drug Profile | 296 | 1 |
| Small Molecules to Inhibit RNA Polymerase for Tuberculosis Drug Profile | 297 | 1 |
| Small Molecules to Inhibit RNA Polymerase for Tuberculosis Drug Profile | 298 | 1 |
| Small Molecules to Inhibit RNA Polymerase for Tuberculosis Drug Profile | 299 | 1 |
| Small Molecules to Inhibit RNA Polymerase for Tuberculosis and Staphylococcus Aureus Infections Drug Profile | 300 | 1 |
| Small Molecules to Inhibit Siderophores for Tuberculosis Drug Profile | 301 | 1 |
| Small Molecules to Inhibit UGM for Tuberculosis and Microbial Infections Drug Profile | 302 | 1 |
| Small Molecules to Target RNA Polymerase for Tuberculosis Drug Profile | 303 | 1 |
| SPR-113 Drug Profile | 304 | 1 |
| SQ-109 Drug Profile | 305 | 3 |
| SQ-609 Drug Profile | 308 | 1 |
| SQ-641 Drug Profile | 309 | 1 |
| SRI-58 Drug Profile | 310 | 1 |
| SSIH-56IC31 Drug Profile | 311 | 2 |
| sutezolid Drug Profile | 313 | 1 |
| T-BioVax Drug Profile | 314 | 1 |